Kikuchi‐Fujimoto disease: investigating comprehensive clinicopathological features and risk factors for recurrence
Histopathology · 2025
DOI: 10.1111/his.15427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Midori Filiz Nishimura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Histiocytic Necrotizing Lymphadenitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Okayama Medical Foundation, Teraoka Scholarship Foundation.
Abstract (Originalsprache)
Aims
Kikuchi‐Fujimoto disease (KFD) is a rare disease that typically manifests with fever and cervical lymphadenopathy. Little is known about the risk factors associated with recurrence and their correlation with clinicopathologic features. Methods and Results We analysed 112 patients with KFD, predominantly female (61/112, 54.5%), with an average age of 29.4 years. The incidence was higher in males up to the age of 20 and higher in females from their 30s onwards. Of the 70 patients with follow‐up data, 23% experienced recurrence. Recurrence was associated with lower C4 levels ( P = 0.038) and higher antinuclear antibody (ANA) rates ( P = 0.007) compared to transient disease. The mean duration of symptoms was 71.5 days. Lymph node histology in 98 cases (excluding 14 needle biopsy specimens) was classified into three patterns: proliferative ( n = 75, 77%), necrotizing ( n = 22, 22%), and xanthomatous ( n = 1, 1%). The necrotizing pattern associated with significantly enlarged lymph nodes ( P = 0.047) and a longer symptom duration ( P = 0.009) than the proliferating pattern. The number of CD4‐positive lymphocytes was significantly lower in the necrotizing type than in the proliferative type ( P < 0.001).
Conclusion
These results indicated that low C4 levels and positive ANA were associated with KFD recurrence. Although the aetiology of KFD remains elusive, given that some cases develop autoimmune disease, the results suggest that patients with recurrent KFD represent an intermediate status between those with transient KFD and those with overt autoimmune disease. The comprehensive clinicopathological findings of this study may be useful for elucidating its pathogenesis and predicting the clinical course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
- Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
- Division of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Pathology and Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
ORCID-Profile: Midori Filiz Nishimura, Yoshito Nishimura, Asami Nishikori, Hidetaka Yamamoto, Yasuharu Sato
Förderung
- Okayama Medical Foundation
- Teraoka Scholarship Foundation
Zitieren
APA
Nishimura, M. F., Sakao, C., Kurokawa, Y., Nishimura, Y., Nishikori, A., Yamamoto, H., & Sato, Y. (2025). Kikuchi‐Fujimoto disease: investigating comprehensive clinicopathological features and risk factors for recurrence. Histopathology. https://doi.org/10.1111/his.15427
Vancouver
Nishimura MF, Sakao C, Kurokawa Y, Nishimura Y, Nishikori A, Yamamoto H, et al. Kikuchi‐Fujimoto disease: investigating comprehensive clinicopathological features and risk factors for recurrence. Histopathology. 2025. doi:10.1111/his.15427
BibTeX
@article{Nishimura2025,
author = {Nishimura, Midori Filiz and Sakao, Chikako and Kurokawa, Yuka and Nishimura, Yoshito and Nishikori, Asami and Yamamoto, Hidetaka and Sato, Yasuharu},
title = {Kikuchi‐Fujimoto disease: investigating comprehensive clinicopathological features and risk factors for recurrence},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15427}
}
EUVIMED